A Study to Evaluate Safety, Pharmacokinetics, and Preliminary Anti-tumor Activity of RO7444973 in Participants With Unresectable and/or Metastatic MAGE-A4-positive Solid Tumors
Clinical trial NCT05129280 · TERMINATED
Trial details
- NCT number
- NCT05129280
- Sponsor
- Hoffmann-La Roche
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-25
- Primary completion
- 2023-07-12
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.